| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |